Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-04

Clinical Trial Update: Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating whether colesevelam affects insulin response in adults with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colesevelam (colesevelam)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2009-12-04